SPONSORED BY SAINT ALPHONSUS. It's a tough subject to talk about. Fecal incontinence affects more than 20 million U.S. adults, making it more common than Alzheimer's Disease or ad ...
Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics R20® rechargeable sacral neuromodulation ...